BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10202672)

  • 1. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua.
    Kommoss F; Schmidt D; Coerdt W; Olert J; Müntefering H
    Int J Gynecol Pathol; 2001 Oct; 20(4):380-5. PubMed ID: 11603223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the alpha-subunit of inhibin in trophoblastic neoplasia.
    Pelkey TJ; Frierson HF; Mills SE; Stoler MH
    Hum Pathol; 1999 Jan; 30(1):26-31. PubMed ID: 9923923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental site nodule and characterization of distinctive types of intermediate trophoblast.
    Shih IM; Seidman JD; Kurman RJ
    Hum Pathol; 1999 Jun; 30(6):687-94. PubMed ID: 10374778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
    Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
    Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the cellular expression of inhibin in trophoblastic tissue.
    McCluggage WG; Ashe P; McBride H; Maxwell P; Sloan JM
    Histopathology; 1998 Mar; 32(3):252-6. PubMed ID: 9568511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
    Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
    Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
    Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
    Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
    Fülöp V; Végh G; Doszpod J
    Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
    Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
    Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor.
    Kurman RJ; Young RH; Norris HJ; Main CS; Lawrence WD; Scully RE
    Int J Gynecol Pathol; 1984; 3(1):101-21. PubMed ID: 6329973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
    Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
    Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study of intermediate trophoblastic non-tumor lesions: exaggerated placental site and placental site nodule].
    Shen DH; Liao XY; Liu YL; Wang H; Yu YZ
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):441-4. PubMed ID: 15498215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma.
    Shih IM; Kurman RJ
    Am J Surg Pathol; 1998 Nov; 22(11):1393-403. PubMed ID: 9808132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
    Bamberger AM; Sudahl S; Wagener C; Löning T
    Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.